Novavax NVAX
NASDAQ NVAX
$9.99 -1.02 (-9.26%)
At close: Oct 22, 2026 · 4:00 PM EDT

Novavax (NVAX) Long-Term Debt Issuances (2012 - 2016)

Updated

Novavax (NVAX) recorded Long-Term Debt Issuances of $42.61 million in FY2025.

Analysis

Novavax (NVAX) Long-Term Debt Issuances (2012 - 2016) Analysis & Trends

Starting with FY2011, Novavax's Long-Term Debt Issuances history includes 6 years.

  • Annual Long-Term Debt Issuances has a three-year compound annual growth rate of -37.6% (FY2022 to FY2025).
  • The FY2025 figure is the highest annual Long-Term Debt Issuances since FY2022.
  • Per Business Quant data, NVAX's Long-Term Debt Issuances was $175.25 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Novavax 1.65 Bn -1.36 Bn 42.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 325.00 Mn
Jun 30, 2013 641,000.00
Mar 31, 2013 809,000.00
Sep 30, 2012 550,000.00
Mar 31, 2012 100,000.00
API Access

Novavax Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=NVAX&period=max&api_key=YOUR_API_KEY